MAPT and amyloidosis: Plasma GFAP distinguished individuals with ongoing brain amyloid deposition (Aβ positive) from those with relatively low amyloid deposition (Aβ negative) compared to p-Tau 181, p-Tau 231, and NFL [30, 32, 81].